scholarly journals 804. Generation of Restriction Factor-Transgenic Cats Using Lentiviral Transgenesis

2010 ◽  
Vol 18 ◽  
pp. S311
2019 ◽  
Vol 93 (11) ◽  
Author(s):  
Olivier Leymarie ◽  
Leslie Lepont ◽  
Margaux Versapuech ◽  
Delphine Judith ◽  
Sophie Abelanet ◽  
...  

ABSTRACTHIV-1 infection of macrophages leads to the sequestration of newly formed viruses in intracellular plasma membrane-connected structures termed virus-containing compartments (VCCs), where virions remain infectious and hidden from immune surveillance. The cellular restriction factor bone marrow stromal cell antigen 2 (BST2), which prevents HIV-1 dissemination by tethering budding viral particles at the plasma membrane, can be found in VCCs. The HIV-1 accessory protein Vpu counteracts the restriction factor BST2 by downregulating its expression and removing it from viral budding sites. Numerous studies described these Vpu countermeasures in CD4+T cells or model cell lines, but the interplay between Vpu and BST2 in VCC formation and HIV-1 production in macrophages is less explored. Here, we show that Vpu expression in HIV-1-infected macrophages enhances viral release. This effect is related to Vpu’s ability to circumvent BST2 antiviral activity. We show that in absence of Vpu, BST2 is enriched in VCCs and colocalizes with capsid p24, whereas Vpu expression significantly reduces the presence of BST2 in these compartments. Furthermore, our data reveal that BST2 is dispensable for the formation of VCCs and that Vpu expression impacts the volume of these compartments. This Vpu activity partly depends on BST2 expression and requires the integrity of the Vpu transmembrane domain, the dileucine-like motif E59XXXLV64and phosphoserines 52 and 56 of Vpu. Altogether, these results highlight that Vpu controls the volume of VCCs and promotes HIV-1 release from infected macrophages.IMPORTANCEHIV-1 infection of macrophages leads to the sequestration of newly formed viruses in virus-containing compartments (VCCs), where virions remain infectious and hidden from immune surveillance. The restriction factor BST2, which prevents HIV-1 dissemination by tethering budding viral particles, can be found in VCCs. The HIV-1 Vpu protein counteracts BST2. This study explores the interplay between Vpu and BST2 in the viral protein functions on HIV-1 release and viral particle sequestration in VCCs in macrophages. The results show that Vpu controls the volume of VCCs and favors viral particle release. These Vpu functions partly depend on Vpu’s ability to antagonize BST2. This study highlights that the transmembrane domain of Vpu and two motifs of the Vpu cytoplasmic domain are required for these functions. These motifs were notably involved in the control of the volume of VCCs by Vpu but were dispensable for the prevention of the specific accumulation of BST2 in these structures.


2012 ◽  
Vol 87 (4) ◽  
pp. 2046-2057 ◽  
Author(s):  
A. Tokarev ◽  
M. Suarez ◽  
W. Kwan ◽  
K. Fitzpatrick ◽  
R. Singh ◽  
...  

Viruses ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 320 ◽  
Author(s):  
Alexandra P. M. Cloherty ◽  
Anusca G. Rader ◽  
Brandon Compeer ◽  
Carla M. S. Ribeiro

Human immunodeficiency virus-1 (HIV-1) persists as a global health concern, with an incidence rate of approximately 2 million, and estimated global prevalence of over 35 million. Combination antiretroviral treatment is highly effective, but HIV-1 patients that have been treated still suffer from chronic inflammation and residual viral replication. It is therefore paramount to identify therapeutically efficacious strategies to eradicate viral reservoirs and ultimately develop a cure for HIV-1. It has been long accepted that the restriction factor tripartite motif protein 5 isoform alpha (TRIM5α) restricts HIV-1 infection in a species-specific manner, with rhesus macaque TRIM5α strongly restricting HIV-1, and human TRIM5α having a minimal restriction capacity. However, several recent studies underscore human TRIM5α as a cell-dependent HIV-1 restriction factor. Here, we present an overview of the latest research on human TRIM5α and propose a novel conceptualization of TRIM5α as a restriction factor with a varied portfolio of antiviral functions, including mediating HIV-1 degradation through autophagy- and proteasome-mediated mechanisms, and acting as a viral sensor and effector of antiviral signaling. We have also expanded on the protective antiviral roles of autophagy and outline the therapeutic potential of autophagy modulation to intervene in chronic HIV-1 infection.


Virology ◽  
2014 ◽  
Vol 468-470 ◽  
pp. 601-608 ◽  
Author(s):  
Bradley S. Barrett ◽  
Kejun Guo ◽  
Michael S. Harper ◽  
Sam X. Li ◽  
Karl J. Heilman ◽  
...  
Keyword(s):  

2014 ◽  
Vol 111 (18) ◽  
pp. E1843-E1851 ◽  
Author(s):  
E. C. Hansen ◽  
K. J. Seamon ◽  
S. L. Cravens ◽  
J. T. Stivers

Science ◽  
2006 ◽  
Vol 314 (5796) ◽  
pp. 95-95 ◽  
Author(s):  
T. Hatziioannou ◽  
M. Princiotta ◽  
M. Piatak ◽  
F. Yuan ◽  
F. Zhang ◽  
...  
Keyword(s):  

2009 ◽  
Vol 19 (1) ◽  
pp. 105-112 ◽  
Author(s):  
Krisztián Kvell ◽  
Tamás Czömpöly ◽  
László Hiripi ◽  
Péter Balogh ◽  
József Kóbor ◽  
...  

1989 ◽  
Vol 162 (3) ◽  
pp. 1553-1559 ◽  
Author(s):  
Hidechika Okada ◽  
Yoichi Nagami ◽  
Kazuhiro Takahashi ◽  
Noriko Okada ◽  
Teru Hideshima ◽  
...  
Keyword(s):  
T Cell ◽  

2004 ◽  
Vol 22 (4) ◽  
pp. 159-160 ◽  
Author(s):  
Alexander Pfeifer ◽  
Andreas Hofmann ◽  
Barbara Kessler ◽  
Eckhard Wolf

Sign in / Sign up

Export Citation Format

Share Document